News Center
2023 08/22 Metagone BREAKING NEWS
TO-O-1001 & TO-O-1002 won the 2023 R&D 100 Award
2023 04 Metagone BREAKING NEWS
MG-O-1002 (TO-O-1002) project won the 2023 Edison Awards™
2022 12 Metagone BREAKING NEWS
ITRI Special Issue ----Interview with Dr. Sean Chen, chairman of TheratOcular Biotek
2022 12 Metagone BREAKING NEWS
New blue ocean for ophthalmology drugs; Taiwanese manufacturers are actively improving innovative technologies
2022 11/24 Metagone BREAKING NEWS
New blue ocean for ophthalmology drugs; Taiwanese manufacturers are actively improving innovative technologies
2022 11/24 Metagone BREAKING NEWS
Old formula New amazing effect, TheratOcular Biotek makes it easy to treat eye diseases - Executive VP Simon Huang Interview
2022 11/18 Metagone BREAKING NEWS
63thAnnual Meeting of Ophthalmology & 15th Asia Pacific Vitreoretinal Society (APVRS) Congress
2022 11/08 Metagone BREAKING NEWS
Press conference of innovative eye drops
2022 09/22 Metagone BREAKING NEWS
TO-O-1002 Investigator meeting (IM) in Thailand
2022 08/15 Metagone BREAKING NEWS
The phase II clinical trial of TO-O-1002 approved by the Central Research Ethics Committee (CREC) in Thailand on 11 Aug 2022.
2022 08/09 Metagone BREAKING NEWS
The phase I/II clinical trials of TO-O-1001 approved by the Australian Human Research Ethics Committee (HREC) on 4 Aug 2022.
2022 08 Metagone BREAKING NEWS
The company Chair, Dr. Sean Chen, and the SAB Chair, Dr. Lu Da-Wen, get together with all the honorary members of the Company Scientific Advisory Board (SAB) in a banquet.
2022 07 Metagone BREAKING NEWS
TheratOcular Team meet up with its RD/BD partner, the ITRI-BEL team, at the 2022 Asia Biotech Exhibition.
2020 12 Metagone BREAKING NEWS
Metagone Biotech drug of lung disease has won 17th WE innovators award
2020 07 Metagone BREAKING NEWS
Metagone MG anti cancer drug has won 2020 Bio@Taipei Award
2020 01 Metagone BREAKING NEWS
Metagone Biotech succeeds in developing new drugs
2019 06 Metagone BREAKING NEWS
【2019 BIO Asia Taiwan Exhibition】 Sincerely invite you to visit us
2019 04 Metagone BREAKING NEWS
MG-S-2525 will complete the Phase 1 Studies
2018 12 Metagone BREAKING NEWS
Granting of Orphan Drug Designation for MG-S-2525 by the FDA
2018 11 Metagone BREAKING NEWS
MG-S-2525 Clinical Trial－Healthy Volunteer Recruitment Information
2018 11 Metagone BREAKING NEWS
MG-D-1509 Clinical Trial－ Volunteer Recruitment
2018 11 Metagone BREAKING NEWS
TFDA approves Clinical Trial Application for MG-S-2525 Phase 1 Studies
2018 11 Metagone BREAKING NEWS
Participated in the 22nd Beijing Biomedical Industry Development Forum to exchange and promote more cooperation.
2018 07 Metagone BREAKING NEWS
信力生技針對肺纖維化疾病(IPF )的MG-S-2525（First in class）小分子新藥通過美國食品藥物管理局（FDA）許可開始進行一期人體臨床試驗
2018 05 Metagone BREAKING NEWS
TFDA approves Clinical Trial Application for MG-D-1509 Phase 1/2a Studies.
2017 11 Metagone BREAKING NEWS
US FDA approves Clinical Trial Application for MG-D-1509 Phase 1/2a Studies.
2016 12 IBMI
Precision Medicine with Novel Raf Inhibitor Combination Therapy and Companion Predictive Biomarker
2015 09
Cancer Research Professional journals reported
2015 08
Metagone Biotech Inc. and National Defense Medical Center have signed a mutual technology transfer license agreement